Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)
Preparing Stock Solutions
1 mg
5 mg
10 mg
1 mM
1.7074 mL
8.5368 mL
17.0736 mL
5 mM
0.3415 mL
1.7074 mL
3.4147 mL
10 mM
0.1707 mL
0.8537 mL
1.7074 mL
50 mM
-
-
-
Description
Mobocertinib (TAK788, AP32788), an investigational TKI, is a potent, selective preclinical inhibitor of and mutations. Mobocertinib (TAK788) is an antineoplastic agent.
Mobocertinib (TAK-788), a novel irreversible EGFR TKI, is specifically designed to potently inhibit oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib inhibits viability of various ex20ins-driven cell lines more potently than approved EGFR TKIs.
